Conmed (CNMD) Change in Accured Expenses (2010 - 2026)

Conmed's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$2.8 million for Q1 2026.

• Quarterly Change in Accured Expenses fell 127.48% year-over-year to -$2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (down 92.22% YoY) and the FY2025 annual result came in at $14.9 million, up 626.22% from the prior year.
• Change in Accured Expenses was -$2.8 million for Q1 2026 at Conmed, down from $5.9 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $14.1 million in Q3 2023 and bottomed at -$19.8 million in Q1 2024.
• A 5-year average of $869117.6 and a median of $5.2 million in 2024 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses tumbled 318.65% — and 2023, when it jumped 621.97%.
• Conmed's Change in Accured Expenses stood at -$13.2 million in 2022, then jumped by 167.91% to $9.0 million in 2023, then tumbled by 41.67% to $5.2 million in 2024, then advanced by 13.27% to $5.9 million in 2025, then slumped by 146.61% to -$2.8 million in 2026.
• Business Quant data shows CNMD's Change in Accured Expenses at -$2.8 million in Q1 2026, $5.9 million in Q4 2025, and $8.1 million in Q3 2025.